Buscar en
Cuadernos de Economía y Dirección de la Empresa CEDE
Toda la web
Inicio Cuadernos de Economía y Dirección de la Empresa CEDE Determinants of Abandoning Innovative Activities: Evidence from Spanish Firms
Información de la revista
Vol. 13. Núm. 45.
Páginas 69-91 (Diciembre 2010)
Descargar PDF
Más opciones de artículo
Vol. 13. Núm. 45.
Páginas 69-91 (Diciembre 2010)
DOI: 10.1016/S1138-5758(10)70024-4
Open Access
Determinants of Abandoning Innovative Activities: Evidence from Spanish Firms
Detrminantes del abandono de actividades de innovacion: Evidencia para la empresa espanola
Maria Garcia-Vega**, Alberto Lopez***
** School of Economics. University of Nottingham. GRIPICO (Group for Research in Productivity, Innovation and Competition)
*** Departamento de Fundamentos del Analisis Economico I. Facultad CC. Economicas y Empresariales. Universidad Complutense de Madrid. Campus de Somosaguas. 28223, Madrid. Spain. Phone: +34 913943158. Fax: +34 913942561
Información del artículo

We empirically analyse the effect of firms’ barriers to innovation on the probability of abandoning innovation projects. Specifically, we study factors related to the availability of finance, knowledge and market conditions. We use a sample of more than 8,300 innovative Spanish firms for the period 2005–2007. We find that all obstacles to innovation have a positive effect on the probability of abandoning innovative activities. Results show that market-related factors seem to be the most important determinants of innovation failure. Analyzing results by firm size, we find that, for small-medium firms, the main factors that lead to abandoning innovative projects are competition from established firms and market uncertainty. In contrast, for large firms, the most important barriers are the lack of qualified personnel and the availability of external finance. These results might suggest that large and small-medium firms differ in the scale and complexity of their innovative projects.

Key words:
Innovation failure
Barriers to innovation
Firm heterogeneity

En este articulo analizamos empiricamente los efectos de los factores que dificultan la innovacion sobre la probabilidad de abandonar actividades de innovacion. Especificamente, estudiamos factores relacionadas con restricciones financieras, factores de cono-cimiento y condiciones de mercado para una muestra de mas de 8.300 empresas innovadoras espanolas para el periodo 2005–2007. Los resultados muestran que todos los obstaculos a la innovacion tienen un efecto positivo sobre la probabilidad de abandono de las actividades de innovacion. Para el conjunto de la muestra, los resultados indican que los condicionantes mas importantes para el abandono son los relacionados con factores de mercado. Diferenciando los resultados por tamano de empresa, encontramos que para las empresas pequenas o medianas, los principales factores que inducen el abandono son los relacionados con la alta competencia por parte de empresas establecidas en el mercado y la incertidumbre en el mercado. Sin embargo, para las empresas grandes, los obstaculos mas importantes son la falta de personal cualificado y la disponibilidad de financiacion. Estos resultados se pueden deber a las diferencias en escala y complejidad que existen entre las actividades de innovacion llevadas a cabo por las empresas grandes y las empresas pequenas o medianas.

Palabras clave:
barreras a la innovacion
heterogeneidad empresarial
El Texto completo está disponible en PDF
[Acemoglu and Linn, 2004]
D. Acemoglu, J. Linn.
Market size in innovation: Theory and evidence from the pharmaceutical industry.
Quarterly Journal of Economics, 119 (2004), pp. 1049-1090
[Acs and Audretsch, 1987]
Z. Acs, D. Audretsch.
Innovation, market share, and firm size.
Review of Economics and Statistics, 69 (1987), pp. 567-575
[Acs and Audretsch, 1988]
Z. Acs, D. Audretsch.
Innovation in large and small firms: An empirical analysis.
American Economic Review, 78 (1988), pp. 678-690
[Baldwin and Le, 2002]
J. Baldwin, Z. Le.
Impediments to advanced technology adoption for Canadian manufacturers.
Research Policy, 31 (2002), pp. 1-18
[Baumol, 2003]
W. Baumol.
Innovation and growth: Two common misapprehensions.
Journal of Policy Modeling, 25 (2003), pp. 435-444
[Canepa and Stoneman, 2002]
A. Canepa, P. Stoneman.
Financial constraints on innovations: A European cross-country study.
Kiel Institute of World Economics, (2002),
[Cassiman and Veugelers, 2002]
B. Cassiman, R. Veugelers.
R&D cooperation and spillovers: some empirical evidence from Belgium.
American Economic Review, 92 (2002), pp. 1169-1184
[Galia and Legros, 2004]
F. Galia, D. Legros.
Complementarities between obstacles to innovation: evidence from France.
Research Policy, 33 (2004), pp. 1185-1199
[Gortz, 1999]
G. Gortz.
Monopolistic competition and the diffusion of new technology.
Rand Journal of Economics, 30 (1999), pp. 679-693
[Hajivassiliou and Savignac, 2008]
V. Hajivassiliou, F. Savignac.
Financing constraints and a firm's decision and ability to innovate: Establishing direct and reverse effects Notes d’Études et de Recherche 202.
Banque de France, (2008),
[Hall and Mairesse, 1995]
B. Hall, J. Mairesse.
Exploring the relationship between R&D and productivity in French manufacturing firms.
Journal of Econometrics, 65 (1995), pp. 263-293
[Hall, 2002]
B.H. Hall.
The Financing of Research and Development.
Oxford Review of Economic Policy, 18 (2002), pp. 35-51
[Huergo and Jaumandreu, 2004]
E. Huergo, J. Jaumandreu.
Firms age, process innovation and productivity growth.
International Journal of Industrial Organization, 22 (2004), pp. 541-559
[Klette, 1996]
T. Klette.
R&D, scope economies, and plant performance.
Rand Journal of Economics, 27 (1996), pp. 502-522
[Landry et al., 2008]
Landry, R.; Amara, N. and N. Becheikh (2008), “Exploring innovation failures in manufacturing industries”, Paper presented at the 25th DRUID Conference. Available at http://www2.druid.dk/conferences/viewpaper.php?id=3378&cf=29.
[Loof and Heshmati, 2006]
H. Loof, A. Heshmati.
On the relationship between innovation and performance: A sensitivity analysis.
Economics of Innovation and New Technology, 15 (2006), pp. 317-344
[Mairesse and Sassenou, 1991]
Mairesse, J. and M. Sassenou (1991), “R&D and productivity: A survey of econometric studies at the firm level” NBER Working Paper 3666.
[Mohnen et al., 2008]
P. Mohnen, F.C. Palm, S.S. van der Loeff, A.K. Tiwari.
Financial constraints and other obstacles: Are they a threat to innovation activity?.
De Economist, 156 (2008), pp. 201-214
[Mohnen et al., 2005]
P. Mohnen, F.C. Palm, S.S. van der Loeff, A.K. Tiwari, L.-H. Roller.
Complementarities in innovation policy.
European Economic Review, 49 (2005), pp. 1431-1450
[Mohnen et al., 2002]
P. Mohnen, F.C. Palm, S.S. van der Loeff, A.K. Roller, L.-H. Rosa, J. Tiwari.
Barriers to innovation in service industries in Canada.
Institutions and Systems in the Geography of Innovation, pp. 231-250
[OECD, 2000]
OECD (2000), “Small and medium-sized enterprises: Local strength, global reach” Available at http://www.oecd.org/dataoecd/3/30/1918307.pdf.
[Savignac, 2008]
F. Savignac.
Impact of financial constraints on innovation: What can be learned from a direct measure?.
Economics of Innovation and New Technology, 17 (2008), pp. 553-569
[Scherer, 1983]
F. Scherer.
The propensity to patent.
International Journal of Industrial Organization 1, (1983), pp. 107-128
[Tiwari et al., 2008]
A.K. Tiwari, P. Mohnen, F.C. Palm, S.S. van der Loeff.
Financial constraints and R&D investment: Evidence from CIS.
Determinants of Innovative Behaviour: A Firm's Internal Practices and its External Environments,
[Tourigny, 2004]
D. Tourigny, C. Le.
Impediments to innovation faced by Canadian manufacturing firms.
Economics of Innovation and New Technology, 13 (2004), pp. 217-250

We would like to thank Bruno Cassiman for his valuable suggestions. We acknowledge support from project SEJ2004-02525/ECON. Errors are ours.

Copyright © 2010. ACEDE
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos